If you are going to venture into micro cap stocks, you need to be wide awake to the fact that there are two alternate universes for the one market segment. There is the conventional world where investors buy and sell interests in businesses that are striving to create value for their... Show More
At the current stage of the bull market, it can be hard to find a company that is reasonably priced, let alone being cheap whilst showing signs of accelerating revenue growth and at a positive inflection point for margins. Something I refer to as a three levered play to generate... Show More
The majority of microcap funds continued their good start to 2019 and the majority of managers appear to have recovered some of the losses suffered in the final quarter of 2018. However, as a group microcap managers are trailing both comparable indexes and the performance of large-cap stocks in 2019. The... Show More
We take our monthly look at the returns of Australian Microcap Funds. The majority of funds endured double-digit and drawdowns in the Dec 18 quarter. This large drawdown in the last quarter also pulled the majority of the funds negative for the calendar year. Show More
What a difference 3 months can make. Investors are nervous with the main Aussie index off about -13% from its highs amidst talk of a bear market. But in small cap land, we are already there. The Emerging Companies Index is down by more than -20% this year, meeting the... Show More
We take our monthly look at the returns of Australian Microcap Funds. While most funds avoided the large drawdowns seen in October the majority still posted small negative absolute returns for November. We can only hope for a late Santa Clause rally to put some gloss on what looks to... Show More
BuildingIQ (BIQ: ASX) Is a stock that is completely off the wider investment radar for a reason that will become obvious in due course. That doesn’t mean though it’s not an interesting investment proposition. Show More
Well, the first quarter of FY19 is behind us and it has been tough for microcaps. As I alluded to in my newsletter last month, reporting season overall was pretty insipid as far as microcaps were concerned. This is reflected in the performance of the index with the S&P/ASX Emerging... Show More
MedAdvisor (MDR: ASX) operates in the healthcare IT space, specifically in improving the interaction between pharmacies, patients, drug manufacturers, doctors, and government. MDR provides a fully digital end to end experience for handling medical scripts for prescribed medication, primarily targeting chronic conditions which require ongoing medication management. Show More
It’s been a while since I bought a stock trading on a PE multiple of 3x. There was one in 2012. Another in 2015. Both were, with a bit of luck, multi-baggers. Show More
